Cyanocobalamin - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for cyanocobalamin and what is the scope of patent protection?
Cyanocobalamin
is the generic ingredient in fifteen branded drugs marketed by Endo Operations, Pharmacia And Upjohn, Lilly, Watson Labs, Abraxis Pharm, Am Regent, Dell Labs, Dr Reddys, Epic Pharma Llc, Eugia Pharma, Fresenius Kabi Usa, Gland Pharma Ltd, Luitpold, Lyphomed, Mankind Pharma, Mylan Institutional, Nanjing King-friend, Norvium Bioscience, Sagent Pharms Inc, Sandoz, Sanofi Aventis Us, Sola Pharms, Solopak, Somerset Theraps Llc, Vitruvias Therap, Warner Chilcott, West-ward Pharms Int, Wyeth Ayerst, Xiromed, Zydus Pharms, Accord Hlthcare, Merck, Bel Mar, Bristol Myers Squibb, Savage Labs, Bayer Hlthcare, Lupin, Padagis Israel, West Ward, Ge Healthcare, and Armour Pharm, and is included in forty-six NDAs. Additional information is available in the individual branded drug profile pages.There are nine drug master file entries for cyanocobalamin. Twenty-three suppliers are listed for this compound.
Summary for cyanocobalamin
US Patents: | 0 |
Tradenames: | 15 |
Applicants: | 41 |
NDAs: | 46 |
Drug Master File Entries: | 9 |
Finished Product Suppliers / Packagers: | 23 |
Raw Ingredient (Bulk) Api Vendors: | 79 |
Clinical Trials: | 39 |
Patent Applications: | 3,563 |
Drug Prices: | Drug price trends for cyanocobalamin |
Drug Sales Revenues: | Drug sales revenues for cyanocobalamin |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for cyanocobalamin |
What excipients (inactive ingredients) are in cyanocobalamin? | cyanocobalamin excipients list |
DailyMed Link: | cyanocobalamin at DailyMed |
Recent Clinical Trials for cyanocobalamin
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Fundação Educacional Serra dos Órgãos | Phase 4 |
University of Kansas Medical Center | Phase 2 |
Tanta University | Phase 3 |
Pharmacology for cyanocobalamin
Drug Class | Vitamin B12 |
Anatomical Therapeutic Chemical (ATC) Classes for cyanocobalamin
Paragraph IV (Patent) Challenges for CYANOCOBALAMIN
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
NASCOBAL | Nasal Spray | cyanocobalamin | 500 mcg/spray | 021642 | 1 | 2017-04-28 |
US Patents and Regulatory Information for cyanocobalamin
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bristol Myers Squibb | RUBRAMIN PC | cyanocobalamin | INJECTABLE;INJECTION | 006799-010 | Apr 28, 1988 | DISCN | Yes | No | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | ||||
Somerset Theraps Llc | CYANOCOBALAMIN | cyanocobalamin | INJECTABLE;INJECTION | 206503-001 | Dec 11, 2015 | AP | RX | No | No | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | |||
Sagent Pharms Inc | CYANOCOBALAMIN | cyanocobalamin | INJECTABLE;INJECTION | 215107-001 | Nov 15, 2022 | AP | RX | No | No | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | |||
Dell Labs | CYANOCOBALAMIN | cyanocobalamin | INJECTABLE;INJECTION | 080689-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | ||||
Abraxis Pharm | CYANOCOBALAMIN | cyanocobalamin | INJECTABLE;INJECTION | 080510-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | ||||
Accord Hlthcare | DODEX | cyanocobalamin | INJECTABLE;INJECTION | 083022-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try for Free | ⤷ Try for Free | ⤷ Try for Free | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for cyanocobalamin
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Endo Operations | NASCOBAL | cyanocobalamin | SPRAY, METERED;NASAL | 021642-001 | Jan 31, 2005 | ⤷ Try for Free | ⤷ Try for Free |
Endo Operations | NASCOBAL | cyanocobalamin | SPRAY, METERED;NASAL | 021642-001 | Jan 31, 2005 | ⤷ Try for Free | ⤷ Try for Free |
Endo Operations | NASCOBAL | cyanocobalamin | SPRAY, METERED;NASAL | 021642-001 | Jan 31, 2005 | ⤷ Try for Free | ⤷ Try for Free |
Endo Operations | NASCOBAL | cyanocobalamin | GEL, METERED;NASAL | 019722-001 | Nov 5, 1996 | ⤷ Try for Free | ⤷ Try for Free |
Endo Operations | NASCOBAL | cyanocobalamin | SPRAY, METERED;NASAL | 021642-001 | Jan 31, 2005 | ⤷ Try for Free | ⤷ Try for Free |
Endo Operations | NASCOBAL | cyanocobalamin | SPRAY, METERED;NASAL | 021642-001 | Jan 31, 2005 | ⤷ Try for Free | ⤷ Try for Free |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Cyanocobalamin Market Dynamics and Financial Trajectory
More… ↓
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.